Previous Article | Next Article 
J Clin Microbiol. 1977 September; 6(3): 303-309
Enrichment medium for the isolation of Bordetella.
J Regan and
F Lowe
ABSTRACT
The development of a specimen collection and transport medium outfit for the rapid laboratory diagnosis of whoping cough is described. The transport medium consisted of a semisolid agar containing charcoal, cephalexin, and defibrinated horse blood. It was also found to be an excellent enrichment medium for the selective isolation of Bordetella pertussis and B. parapertussis from scantily populated specimens. The investigation of 3,237 specimens that yielded 1,419 positive isolates of Bordetella, including 86 B. parapertussis, during a 20-month period is presented. A total of 3,076 specimens were processed in the laboratory by using the enrichment medium in addition to the routine procedure. Of these specimens, 757 were submitted in our medium, from which 137 (18%) were positive. Of the 567 specimens received in Amies transport medium, 290 (51%) positive cultures were obtained by the enrichment method only and not by primary culture.
J Clin Microbiol. 1977 September; 6(3): 303-309
This article has been cited by other articles:
-
She, R. C., Billetdeaux, E., Phansalkar, A. R., Petti, C. A.
(2007). Limited Applicability of Direct Fluorescent-Antibody Testing for Bordetella sp. and Legionella sp. Specimens for the Clinical Microbiology Laboratory. J. Clin. Microbiol.
45: 2212-2214
[Abstract]
[Full Text]
-
Langley, J. M., Halperin, S. A., Boucher, F. D., Smith, B., Pediatric Investigators Collaborative Network on I,
(2004). Azithromycin Is as Effective as and Better Tolerated Than Erythromycin Estolate for the Treatment of Pertussis. Pediatrics
114: e96-e101
[Abstract]
[Full Text]
-
Nygren, M., Reizenstein, E., Ronaghi, M., Lundeberg, J.
(2000). Polymorphism in the Pertussis Toxin Promoter Region Affecting the DNA-Based Diagnosis of Bordetella Infection. J. Clin. Microbiol.
38: 55-60
[Abstract]
[Full Text]
-
Halperin, S. A., Bortolussi, R., Langley, J. M., Eastwood, B. J., De Serres, G.
(1999). A Randomized, Placebo-Controlled Trial of Erythromycin Estolate Chemoprophylaxis for Household Contacts of Children With Culture-Positive Bordetella pertussis Infection. Pediatrics
104: 42e-42
[Abstract]
[Full Text]
-
Lind-Brandberg, L., Welinder-Olsson, C., Lagergård, T., Taranger, J., Trollfors, B., Zackrisson, G.
(1998). Evaluation of PCR for Diagnosis of Bordetella pertussis and Bordetella parapertussis Infections. J. Clin. Microbiol.
36: 679-683
[Abstract]
[Full Text]
-
Heininger, U., Klich, K., Stehr, K., Cherry, J. D.
(1997). Clinical Findings in Bordetella pertussis Infections: Results of a Prospective Multicenter Surveillance Study. Pediatrics
100: e10-e10
[Abstract]
[Full Text]
-
Halperin, S. A., Bortolussi, R., Langley, J. M., Miller, B., Eastwood, B. J.
(1997). Seven Days of Erythromycin Estolate Is as Effective as Fourteen Days for the Treatment of Bordetella pertussis Infections. Pediatrics
100: 65-71
[Abstract]
[Full Text]
-
Gustafsson, L., Hallander, H. O., Olin, P., Reizenstein, E., Storsaeter, J.
(1996). A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis Vaccine. NEJM
334: 349-356
[Abstract]
[Full Text]
-
Trollfors, B., Taranger, J., Lagergard, T., Lind, L., Sundh, V., Zackrisson, G., Lowe, C. U., Blackwelder, W., Robbins, J. B.
(1995). A Placebo-Controlled Trial of a Pertussis-Toxoid Vaccine. NEJM
333: 1045-1050
[Abstract]
[Full Text]
-
Christie, C., Marx, M. L., Marchant, C. D., Reising, S. F.
(1994). The 1993 Epidemic of Pertussis in Cincinnati -- Resurgence of Disease in a Highly Immunized Population of Children. NEJM
331: 16-21
[Abstract]
[Full Text]
Copyright © 1977 by the American Society for Microbiology. All rights reserved.